about
Calcium channel blockers for pulmonary arterial hypertensionTime course for blood pressure lowering of dihydropyridine calcium channel blockersCalcium channel blockers for pulmonary arterial hypertensionTime course for blood pressure lowering of dihydropyridine calcium channel blockersPharmacological implications of the Ca(2+)/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disordersShort-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsLong-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionCardiovascular autophagy: crossroads of pathology, pharmacology and toxicologyIon Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisEffects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China.Phenotypic screens as a renewed approach for drug discovery.Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library.Somatic Comorbidity in Chronic Constipation: More Data from the GECCO Study.Relationship between calcium channel blocker class and mortality in dialysis.Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS studyEfficacy of intravenous sedation and oral nifedipine in dental implant patients with preoperative hypertension - a retrospective study of 516 cases.7th Brazilian Guideline of Arterial Hypertension: Chapter 7 - Pharmacological TreatmentNew insights into hypertension-associated erectile dysfunction.Putative impact of RNA editing on drug discovery.Ca(2+) Signalling in Endothelial Progenitor Cells: Friend or Foe?Tolerability of Antihypertensive Medications in Older Adults.Management of Hypertension With a Fixed-Dose (Single-Pill) Combination of Bisoprolol and Amlodipine.Can balneotherapy improve the bowel motility in chronically constipated middle-aged and elderly patients?Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier.Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.Verapamil and vasospastic angina: underuse in the elderly population.Reduction of blood pressure by store-operated calcium channel blockers.Quality of compounded topical 2% diltiazem hydrochloride formulations for anal fissure.Effect of antihypertensive agents - captopril and nifedipine - on the functional properties of rat heart mitochondria.Diltiazem reduces mortality and breakdown of ATP in red blood cell induced by isoproterenol in a freely moving rat model in vivo.Population pharmacokinetics of digoxin in elderly patients.Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.Convenient iron-catalyzed reductive aminations without hydrogen for selective synthesis of N-methylamines.Verapamil-induced breakdown of the blood-brain barrier presenting as a transient right middle cerebral artery syndrome.The effects of medication use in transcranial direct current stimulation: A brief review.Cluster headache management and beyond.Hypertension and Exercise Training: Evidence from Clinical Studies.The effects of verapamil and its combinations with glutamate and glycine on cardiodynamics, coronary flow and oxidative stress in isolated rat heart.Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.Attenuation of Hemodynamic Responses to Endotracheal Extubation with Different Doses of Diltiazem with Lignocaine: A Placebo-Controlled Study.
P2860
Q24187010-C0A94A64-DF5F-494E-AA35-1167F5F3F358Q24194238-36A8E611-0AA2-4F21-88AA-956BCF45F73BQ24200926-1C7848C2-12B3-4504-8853-D2B5F79F90BFQ24201835-D712E533-2CC4-4E35-9F27-06542C144245Q26777845-5965F232-DFEB-4FA1-B10A-0EB100A1C211Q26778578-FD0DD6E7-32EE-4365-BD78-3C746201FA03Q26824261-634BC637-12D6-496C-BD67-2F39BFA96F79Q26858902-E04E4983-6365-4550-9C48-BA92D94BCDC7Q28550401-8FBB7147-A1E7-4DF1-983C-1C8CA6A4F784Q35044523-A92FF77D-8BE4-476A-BA04-B5C5AB87CE25Q35936197-58968310-BD0F-4FD7-9DD5-B7590A177D5BQ36172912-B2A0936B-829B-4D2B-AF12-688C1E411694Q36185124-249E3495-5388-43E9-B09A-DBFCD893C867Q36469666-B90DCE68-98C4-4C9A-9D67-BF8B20C55C43Q36952295-548F5D7E-ECB5-49C4-B145-C4AFBF862B36Q37167505-8AEB771C-366D-4458-92CE-8D1FAAA5D983Q37656205-5F733426-63A7-446E-8B18-CB0BDAABAE43Q37731719-09BC16DA-F279-4E58-9F17-4AB82583C868Q38068563-8D16A31D-D594-4010-817E-20E6890DA78FQ38561600-D6FBB9B9-8C34-4552-AA8E-1A54E022953FQ38600758-44006110-D276-449C-A598-4E2DC38725B9Q38960658-04385475-EDAF-4638-B68A-0B4243213B4DQ39067356-0AD0C23E-7BDB-4DAD-902C-466DC92879DAQ39239140-B5CDF53D-4F5B-4008-BBC5-DF39D03BAA5EQ40950708-58111B27-675D-4D0E-B9FF-B39D9109643AQ41265426-6FDA88D6-9196-47BC-B2E0-5D4EF444ACA7Q42019668-A4579275-27CC-45CC-AC30-B01E9580F4D0Q42124733-15D7BE80-A50A-4D5E-A8E1-44033E3DEB53Q42412744-8016DDA1-8977-456F-BC19-B9C5C0211155Q42939189-D8FD04D3-5B02-44B6-8741-2BD93CE3B5B5Q43750581-DDFE57A4-7DDB-431D-B29D-A266804FDEB5Q47125921-947B3EC0-DBCA-4392-BFDD-4DB3EB187F62Q47127894-CFB8C00D-83AE-46E9-AA64-D1CA0D42B5D2Q47623924-CF275E60-DFF5-4592-A0C1-9DE1178F997DQ47729862-2F375C7B-7157-47F3-A0D3-FD1A7A4713DEQ47968905-EA8593FE-BFF7-4211-80C1-3E123E6F0FACQ47988966-9E551DDB-9F94-4B35-8DE2-70204B8B8A68Q51345127-F325E60A-56E1-4A03-BFAD-8C3CE4BFBA18Q54475917-DFAD0BF8-9A25-4682-8565-4D574AD783C3Q55513134-AAC518B3-544E-45D7-B279-64C78A6D92B3
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Calcium channel blockers
@ast
Calcium channel blockers
@en
Calcium channel blockers
@nl
type
label
Calcium channel blockers
@ast
Calcium channel blockers
@en
Calcium channel blockers
@nl
prefLabel
Calcium channel blockers
@ast
Calcium channel blockers
@en
Calcium channel blockers
@nl
P2860
P3181
P1476
Calcium channel blockers
@en
P2093
C. Venkata S. Ram
William J. Elliott
P2860
P3181
P356
10.1111/J.1751-7176.2011.00513.X
P407
P577
2011-09-01T00:00:00Z